Literature DB >> 6974894

The effects of variable age-of-onset and diagnostic criteria on the estimates of linkage: an example using manic-depressive illness and color blindness.

L A Morton, K K Kidd.   

Abstract

Three pedigrees were selected from the literature for their compatibility with the hypothesis of linkage between the X-chromosome marker color blindness and bipolar affective disorder. We compared the results of linkage analyses of these pedigrees when both penetrance function and diagnostic classification were varied. The analyses show that the incorporation of age-of-onset information into a penetrance function significantly increased the evidence for linkage. In addition, assumptions about diagnostic classification affected the lod scores. These results demonstrate the need for careful consideration of diagnostic criteria and variable age-of-onset when pursuing linkage analysis of complex traits.

Entities:  

Mesh:

Year:  1980        PMID: 6974894     DOI: 10.1080/19485565.1980.9988398

Source DB:  PubMed          Journal:  Soc Biol        ISSN: 0037-766X


  4 in total

1.  An additive genetic gamma frailty model for linkage analysis of diseases with variable age of onset using nuclear families.

Authors:  Hongzhe Li
Journal:  Lifetime Data Anal       Date:  2002-12       Impact factor: 1.588

2.  Considerations in using linkage analysis as a presymptomatic test for Huntington's disease.

Authors:  L A Farrer; R H Myers; L A Cupples; P M Conneally
Journal:  J Med Genet       Date:  1988-09       Impact factor: 6.318

3.  Analyzing twin resemblance in multisymptom data: genetic applications of a latent class model for symptoms of conduct disorder in juvenile boys.

Authors:  L J Eaves; J L Silberg; J K Hewitt; M Rutter; J M Meyer; M C Neale; A Pickles
Journal:  Behav Genet       Date:  1993-01       Impact factor: 2.805

4.  DSM-III-R schizotypal personality traits in offspring of schizophrenic disorder, affective disorder, and normal control parents.

Authors:  E Squires-Wheeler; A E Skodol; A Bassett; L Erlenmeyer-Kimling
Journal:  J Psychiatr Res       Date:  1989       Impact factor: 4.791

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.